No link between early childhood cancers and living near mobile phone base station during pregnancy, says study

A new study finds no association between a mother living near to a mobile phone base station during her pregnancy and the risk of that child developing cancer before reaching the age of five <em>- News</em>

Imperial College London News Release
Under STRICT EMBARGO for
00.01 BST
Wednesday 23 June 2010

A new study looking at the patterns of early childhood cancers across Great Britain has found no association between a mother living near to a mobile phone base station during her pregnancy and the risk of that child developing cancer before reaching the age of five.

The study, published today on bmj.com, is the first to look at the health effects of mobile phone base stations in Great Britain as a whole, and is the largest of its kind.

Use of mobile (cellular) phones has increased markedly in recent years and questions have been raised about possible health effects, including brain and other cancers, especially after prolonged use.

Opinion surveys also indicate high levels of public concern about the potential risks of living near mobile phone base stations.

Previous reports of apparent cancer clusters near mobile phone base stations are difficult to interpret, due to small numbers and possible biases that could have affected the results. There is also a lack of any radiobiological explanation for such cancer excesses.

Opinion surveys have indicated public concern about potential health risks of mobile phone base stations

For today's study, researchers from Imperial College London looked at almost 7,000 children and explored whether there was any correlation between a mother living near a mobile phone base station during her pregnancy and that child's risk of developing cancer.

The researchers identified 1,397 British children aged 0-4 years, who were registered with leukaemia or a tumour in the brain or central nervous system between 1999 and 2001.

The researchers compared data on how close the children's birth addresses were to a mobile phone base station, with the same data on children selected as controls. For each child with cancer, four healthy children who shared the same gender and birth date were chosen at random to act as controls.

They were unable to take account of the proportion of mothers who might have moved to the birth address from another address during their pregnancy, because these data were unavailable.

The researchers analysed the approximate distance (in metres) between the birth address and the nearest mobile phone base station, the total power output for base stations within 700m of the birth address, and the power density for base stations within 1400m of the birth address.

They used this information to compare estimates of the mothers' radio frequency exposures from mobile phone base stations over nine months of pregnancy.

The patterns that they identified revealed that the children with cancer are no more likely to have a birth address near a base station than those who do not have cancer. The estimated radio frequency exposures to mobile phone base stations were similar for the mothers of children with cancer and the children acting as controls.

Professor Paul Elliott, Director of the MRC-HPA Centre for Environment and Health at Imperial College London, who is the corresponding author of the study, said: "People are worried that living near a mobile phone mast might affect their children's health. We looked at this question with respect to risk of cancers in young children. We found no pattern to suggest that the children of mums living near a base station during pregnancy had a greater risk of developing cancer than those who lived elsewhere."

The researchers point out that there are a number of aspects of childhood cancer and exposure to mobile phone base stations that this study was not able to investigate. They would like to analyse whether there is any association between children's own exposure to mobile phone base stations and their risk of developing cancer - for today's study, complete data were only available on the children's birth addresses and not the addresses where they might subsequently have moved to. Also, the mothers' and children's details were identified from national registers and the researchers did not have individual contact with them.

Today's study was funded by the Mobile Telecommunications and Health Research (MTHR) Programme.

Professor Elliott is Principal Investigator for the UK arm of the cohort study on mobile communications (COSMOS), which launched in April 2010, which is also part of the MTHR Programme. This international study will run for 20-30 years and will follow the health of around 250,000 participants aged 18-69 in five European countries.

-Ends-

For further information please contact:
Laura Gallagher
Research Media Relations Manager
Imperial College London
email:l.gallagher@imperial.ac.uk
Tel: +44(0)20 7594 8432
Out of hours duty press officer: +44(0)7803 886 248

Notes to editors:

1. "Mobile phone base stations and early childhood cancers: case-control study" British Medical Journal, 22 June 2010

Corresponding author: Paul Elliott, Imperial College London (for full list of authors please see study)

2. For almost 100 years the Medical Research Council has improved the health of people in the UK and around the world by supporting the highest quality science. The MRC invests in world-class scientists. It has produced 29 Nobel Prize winners and sustains a flourishing environment for internationally recognised research. The MRC focuses on making an impact and provides the financial muscle and scientific expertise behind medical breakthroughs, including one of the first antibiotics penicillin, the structure of DNA and the lethal link between smoking and cancer. Today MRC funded scientists tackle research into the major health challenges of the 21st century. www.mrc.ac.uk

3. The Health Protection Agency identifies and responds to health hazards and emergencies caused by radiation, poisons, hazardous chemicals and infectious disease. It gives advice to the public on how to stay healthy and avoid health hazards, provides data and information to government to help inform its decision making, and advises people working in healthcare.

The Agency combines public health and scientific knowledge, research and emergency planning within one organisation - and works at international, national, regional and local levels. It also supports and advises other organisations that play a part in protecting health.

The Agency's advice, information and services are underpinned by evidence-based research. It also uses its research to develop new vaccines and treatments that directly help patients. Although set up by Government, the Agency is independent and provides whatever advice and information is necessary to protect public health. www.hpa.org.uk

4. About Imperial College London

Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explo res the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.

Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.

In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.

Website: www.imperial.ac.uk